APA (7th ed.) Citation

BP, J., AF, H., S, S., DA, T., EA, O., G, B., & K, S. (2019). Extended-release injectable naltrexone (XR-NTX): A response to clinical issues raised by Brewer & Streel. Addiction (Abingdon, England), 114(1), 189. https://doi.org/10.1111/add.14462

Chicago Style (17th ed.) Citation

BP, Jarvis, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow G, and Silverman K. "Extended-release Injectable Naltrexone (XR-NTX): A Response to Clinical Issues Raised by Brewer & Streel." Addiction (Abingdon, England) 114, no. 1 (2019): 189. https://doi.org/10.1111/add.14462.

MLA (9th ed.) Citation

BP, Jarvis, et al. "Extended-release Injectable Naltrexone (XR-NTX): A Response to Clinical Issues Raised by Brewer & Streel." Addiction (Abingdon, England), vol. 114, no. 1, 2019, p. 189, https://doi.org/10.1111/add.14462.